Oncopeptides AB (publ) (ONPPF)
USD 0.27
(-70.56%)
USD 0.27
(-70.56%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 35.22 Million SEK | 321.54% |
| 2022 | 8.35 Million SEK | -92.94% |
| 2021 | 118.29 Million SEK | 0.0% |
| 2020 | - SEK | 0.0% |
| 2019 | - SEK | 0.0% |
| 2018 | - SEK | 0.0% |
| 2017 | - SEK | 0.0% |
| 2016 | - SEK | 0.0% |
| 2015 | - SEK | 0.0% |
| 2014 | - SEK | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 8.15 Million SEK | 60.78% |
| 2024 Q1 | 5.07 Million SEK | -4.97% |
| 2023 Q2 | 25.95 Million SEK | 2209.07% |
| 2023 Q3 | 2.8 Million SEK | -89.19% |
| 2023 Q1 | 1.12 Million SEK | 100.71% |
| 2023 Q4 | 5.33 Million SEK | 90.27% |
| 2023 FY | 35.22 Million SEK | 321.54% |
| 2022 Q1 | - SEK | 100.0% |
| 2022 FY | 8.35 Million SEK | -92.94% |
| 2022 Q2 | 8.75 Million SEK | 0.0% |
| 2022 Q4 | 560 Thousand SEK | 158.46% |
| 2022 Q3 | -958 Thousand SEK | -110.94% |
| 2021 Q4 | -21.71 Million SEK | -140.0% |
| 2021 FY | 118.29 Million SEK | 0.0% |
| 2021 Q1 | 19.35 Million SEK | 0.0% |
| 2021 Q2 | 66.37 Million SEK | 242.93% |
| 2021 Q3 | 54.27 Million SEK | -18.23% |
| 2020 Q4 | - SEK | 0.0% |
| 2020 Q3 | - SEK | 0.0% |
| 2020 Q1 | - SEK | 0.0% |
| 2020 FY | - SEK | 0.0% |
| 2020 Q2 | - SEK | 0.0% |
| 2019 Q3 | - SEK | 0.0% |
| 2019 FY | - SEK | 0.0% |
| 2019 Q4 | - SEK | 0.0% |
| 2019 Q2 | - SEK | 0.0% |
| 2019 Q1 | - SEK | 0.0% |
| 2018 Q1 | - SEK | 0.0% |
| 2018 FY | - SEK | 0.0% |
| 2018 Q4 | - SEK | 0.0% |
| 2018 Q3 | - SEK | 0.0% |
| 2018 Q2 | - SEK | 0.0% |
| 2017 Q4 | - SEK | 0.0% |
| 2017 Q1 | - SEK | 0.0% |
| 2017 Q2 | - SEK | 0.0% |
| 2017 Q3 | - SEK | 0.0% |
| 2017 FY | - SEK | 0.0% |
| 2016 Q1 | - SEK | 0.0% |
| 2016 Q2 | - SEK | 0.0% |
| 2016 Q4 | - SEK | 0.0% |
| 2016 FY | - SEK | 0.0% |
| 2016 Q3 | - SEK | 0.0% |
| 2015 FY | - SEK | 0.0% |
| 2014 FY | - SEK | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Qrons Inc. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 48.35 Million USD | 27.162% |
| Skye Bioscience, Inc. | - USD | -Infinity% |
| Santhera Pharmaceuticals Holding AG | 122.95 Million USD | 71.355% |
| Nascent Biotech, Inc. | - USD | -Infinity% |
| Adynxx, Inc. | - USD | -Infinity% |
| Acro Biomedical Co., Ltd. | 658.5 Thousand USD | -5248.519% |
| BioStem Technologies, Inc. | 16.68 Million USD | -111.083% |
| CSL Limited | 14.69 Billion USD | 99.76% |
| Evofem Biosciences, Inc. | 18.21 Million USD | -93.325% |
| Arch Therapeutics, Inc. | 75.72 Thousand USD | -46411.014% |
| Regen BioPharma, Inc. | 236.56 Thousand USD | -14788.4% |
| Northwest Biotherapeutics, Inc. | 1.93 Million USD | -1722.981% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Eiger BioPharmaceuticals, Inc. | 15.77 Million USD | -123.293% |
| Nanobac Pharmaceuticals, Incorporated | 17.62 Thousand USD | -199775.149% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| SQZ Biotechnologies Company | 21.47 Million USD | -63.982% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | -53484.469% |
| Propanc Biopharma, Inc. | - USD | -Infinity% |
| Mesoblast Limited | 5.9 Million USD | -496.747% |
| Marizyme, Inc. | 645.81 Thousand USD | -5353.616% |
| Genus plc | 668.8 Million USD | 94.734% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| Pharming Group N.V. | 245.31 Million USD | 85.643% |
| Therapeutic Solutions International, Inc. | 98.99 Thousand USD | -35477.914% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | -8486.788% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| ContraFect Corporation | - USD | -Infinity% |
| PsyBio Therapeutics Corp. | - USD | -Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | -45782.675% |
| IMV Inc. | - USD | -Infinity% |
| AXIM Biotechnologies, Inc. | 39.51 Thousand USD | -89023.944% |
| MultiCell Technologies, Inc. | 49.32 USD | -71411092.214% |
| ONE Bio Corp. | 52.29 Million USD | 32.653% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 49.72 Million USD | 29.165% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 48.9 Thousand USD | -71924.54% |
| Q BioMed Inc. | 284.35 Thousand USD | -12286.057% |
| Emmaus Life Sciences, Inc. | 29.59 Million USD | -18.999% |
| Mosaic ImmunoEngineering Inc. | - USD | -Infinity% |
| Biomind Labs Inc. | - USD | -Infinity% |
| American Oriental Bioengineering, Inc. | 145.09 Million USD | 75.727% |
| Provectus Biopharmaceuticals, Inc. | 557.71 Thousand USD | -6215.11% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | -50214.286% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | - USD | -Infinity% |
| Curative Biotechnology, Inc. | - USD | -Infinity% |
| GB Sciences, Inc. | - USD | -Infinity% |
| Alpha Cognition Inc. | - USD | -Infinity% |
| HST Global, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Halberd Corporation | 999.00 USD | -3525425.526% |
| Enzolytics Inc. | 52.79 Thousand USD | -66609.599% |
| Agentix Corp. | - USD | -Infinity% |
| Resverlogix Corp. | - USD | -Infinity% |
| Nuo Therapeutics, Inc. | 608.52 Thousand USD | -5687.765% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 1.22 Billion USD | 97.128% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | 140.24 Thousand USD | -25013.732% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | -5604.715% |
| Zenith Capital Corp. | - USD | -Infinity% |
| Genscript Biotech Corporation | 839.52 Million USD | 95.805% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | - USD | -Infinity% |
| WPD Pharmaceuticals Inc. | - USD | -Infinity% |
| Cotinga Pharmaceuticals Inc. | - USD | -Infinity% |
| Kadimastem Ltd | - USD | -Infinity% |
| Helix BioMedix, Inc. | 997.72 Thousand USD | -3430.027% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | - USD | -Infinity% |
| LadRx Corporation | - USD | -Infinity% |
| Cell Source, Inc. | - USD | -Infinity% |
| Regen BioPharma, Inc. | 236.56 Thousand USD | -14788.4% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Affymax, Inc. | 1.36 Million USD | -2472.681% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| CytoDyn Inc. | - USD | -Infinity% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 473.73 Thousand USD | -7334.615% |
| SYBLEU INC | 11.69 Thousand USD | -301028.591% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | -Infinity% |
| International Stem Cell Corporation | 7.78 Million USD | -352.176% |
| Bioxytran, Inc. | - USD | -Infinity% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 13 Thousand USD | -270823.077% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | - USD | -Infinity% |
| Neutra Corp. | 39.53 Thousand USD | -88987.874% |
| Windtree Therapeutics, Inc. | - USD | -Infinity% |
| PureTech Health plc | 3.33 Million USD | -957.658% |
| Coeptis Therapeutics, Inc. | - USD | -Infinity% |
| IXICO plc | 6.66 Million USD | -428.432% |
| IntelGenx Technologies Corp. | 1.03 Million USD | -3289.798% |
| Gelesis Holdings, Inc. | 25.76 Million USD | -36.686% |
| CSL Limited | 14.8 Billion USD | 99.762% |
| Cellectis S.A. | 755 Thousand USD | -4564.901% |